A carregar...
Targeting NRF2 for the Treatment of Friedreich’s Ataxia: A Comparison among Drugs
NRF2 (Nuclear factor Erythroid 2-related Factor 2) signaling is impaired in Friedreich’s Ataxia (FRDA), an autosomal recessive disease characterized by progressive nervous system damage and degeneration of nerve fibers in the spinal cord and peripheral nerves. The loss of frataxin in patients result...
Na minha lista:
| Publicado no: | Int J Mol Sci |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6829337/ https://ncbi.nlm.nih.gov/pubmed/31640150 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms20205211 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|